A previous study reported that erythropoietin production is increased in a compensatory manner in PARP-2-/- mice and contributes to the maintenance of erythropoiesis, thus suggesting that erythropoietin may have an effect on ameliorating the risk of severe anemia (9). This evidence concerns the gene EPO and anemia.